Company profile for Ceapro

NEW Drugs in Dev: 5
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ceapro Inc. (TSX-V: CZO) is a Canadian biotechnology company involved in the development and commercialization of "active ingredients" derived from oats and other renewable plant resources for healthcare and cosmetic industries. The Company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharm...
Ceapro Inc. (TSX-V: CZO) is a Canadian biotechnology company involved in the development and commercialization of "active ingredients" derived from oats and other renewable plant resources for healthcare and cosmetic industries. The Company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
7824-51 Avenue NW Edmonton, Alberta T6E 6W2
Telephone
Telephone
780.421.4555
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/04/01/3053872/0/en/COSCIENS-Biopharma-Inc-Announces-Receipt-of-Management-Cease-Trade-Order.html

GLOBENEWSWIRE
01 Apr 2025

https://www.globenewswire.com/news-release/2024/09/23/2951281/0/en/COSCIENS-Biopharma-Inc-Provides-Updates-on-Merger-Integration-Management-Succession-Plans-and-Ongoing-Development-Programs.html

GLOBENEWSWIRE
23 Sep 2024

https://www.globenewswire.com/news-release/2024/06/03/2892323/0/en/Aeterna-Zentaris-and-Ceapro-Complete-Merger-Transaction.html

GLOBENEWSWIRE
03 Jun 2024

https://www.globenewswire.com/news-release/2024/05/29/2889961/0/en/Ceapro-Inc-Reports-Financial-Results-for-First-Quarter-2024-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
29 May 2024

https://www.globenewswire.com/news-release/2024/04/29/2871275/0/en/Ceapro-Inc-Reports-2023-Financial-Results-and-Operational-Highlights.html

GLOBENEWSWIRE
29 Apr 2024

https://www.globenewswire.com//news-release/2024/03/12/2844946/0/en/Aeterna-Zentaris-and-Ceapro-Merger-Approved-by-Securityholders-at-Special-Meetings.html

GLOBENEWSWIRE
12 Mar 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty